Tempus AI Surges 5.8% Amid Sector Divergence: What's Fueling the Rally?

Generated by AI AgentTickerSnipeReviewed byAInvest News Editorial Team
Monday, Jan 12, 2026 12:08 pm ET2min read

Summary

(TEM) surges 5.8% to $70.14, trading above its 52-week low of $36.22
• Intraday range spans $69.62 to $76.33, with turnover hitting 10.38 million shares
• Leveraged ETF (TEMT) jumps 11.3%, amplifying the stock's momentum
• Healthcare Equipment sector leader Medtronic (MDT) declines 1.38%, highlighting sector divergence

Tempus AI’s sharp intraday rebound has ignited investor curiosity amid a broader sector slump. The stock’s 5.8% gain—despite a lack of company-specific news—suggests a mix of technical momentum and speculative positioning. With the 2X leveraged ETF

surging in lockstep, the rally underscores a strategic inflection point for the AI-driven healthcare innovator.

Technical Momentum Outpaces Sector Weakness
The surge in Tempus AI appears driven by a confluence of technical factors rather than fundamental catalysts. The stock’s short-term bullish trend, confirmed by a positive MACD histogram (0.94) and RSI (58.19) hovering above 50, has attracted algorithmic and retail buyers. High turnover (9.99% of float) and a 5.8% intraday rebound from the 200-day MA ($68.23) suggest a short-covering rally. The absence of company news or sector-specific events points to speculative positioning ahead of the January 16 options expiration, with traders capitalizing on the stock’s volatility premium.

Healthcare Equipment Sector Sinks as Medtronic Drags
While Tempus AI defies the sector’s downward drift, Medtronic (MDT) declines 1.38%, reflecting broader healthcare equipment sector fragility. The sector’s underperformance—compounded by macroeconomic concerns and regulatory scrutiny—contrasts with TEM’s technical rebound. This divergence highlights TEM’s speculative appeal amid a risk-off environment, where AI-driven healthcare plays are being selectively rotated into despite sector-wide headwinds.

Capitalizing on Volatility: ETF and Options Playbook
200-day average: $68.23 (above current price)
RSI: 58.19 (neutral to bullish)
MACD: -1.66 (bullish crossover potential)
Bollinger Bands: 73.19 (upper), 65.60 (middle), 58.02 (lower)
Key support/resistance: 64.34–64.71 (30D), 58.36–59.68 (200D)

Tempus AI’s technical setup favors a bullish bias, with the 2X leveraged ETF TEMT (15.85, +11.3%) offering amplified exposure. The stock’s proximity to the 200-day MA and its position within the upper Bollinger Band (73.19) suggest a continuation of the rebound. For options traders, the

and contracts stand out:

TEM20260116C70 (Call, $70 strike, Jan 16 exp):
- IV: 80.49% (high volatility)
- LVR: 26.32% (high leverage)
- Delta: 0.52 (moderate directional sensitivity)
- Theta: -0.546 (rapid time decay)
- Gamma: 0.060 (strong price sensitivity)
- Turnover: 402,264 (high liquidity)
- Payoff at 5% upside (73.65): $3.65 per contract
- This contract balances leverage and liquidity, ideal for a short-term bullish bet.

TEM20260116C72 (Call, $72 strike, Jan 16 exp):
- IV: 79.89% (high volatility)
- LVR: 39.12% (extreme leverage)
- Delta: 0.40 (moderate directional sensitivity)
- Theta: -0.474 (rapid time decay)
- Gamma: 0.059 (strong price sensitivity)
- Turnover: 406,368 (high liquidity)
- Payoff at 5% upside (73.65): $1.65 per contract
- Aggressive bulls may target this for high-reward potential, though its lower delta requires a sharper move.

Aggressive bulls may consider TEM20260116C70 into a bounce above $73.19.

Backtest Tempus AI Stock Performance
Backtesting TEM's performance after a 6% intraday surge from 2022 to now is not currently possible due to insufficient data. The available data does not contain any intraday surge events meeting the 6% threshold, which is a requirement for a valid event-driven backtest. As a result, no statistics can be computed for this scenario.

Bullish Technicals and Volatility Playbook: Act Now
Tempus AI’s technical setup suggests a continuation of its rebound, with the 200-day MA and Bollinger Bands acting as key guides. The stock’s divergence from the underperforming healthcare sector—led by Medtronic’s 1.38% decline—highlights its speculative appeal. Traders should monitor the 73.19 upper Bollinger Band as a critical resistance level and the 65.60 middle band for potential support. With the 2X leveraged ETF TEMT amplifying exposure and high-liquidity options like TEM20260116C70 available, the case for a short-term bullish trade is compelling. Watch for a break above $73.19 or a breakdown below $65.60 to confirm direction.

Unlock Market-Moving Insights.

Subscribe to PRO Articles.

  • AI-Driven Trading Signals - 24/7 Market Opportunities.
  • Ultra-Timely & Actionable - Translate events directly into clear portfolio strategies.
  • Diverse Assets Coverage - Options, 0DTE, ETFs, and Cryptos.
  • Get 7-Day FREE Pro Articles - Sign Up Now

    Learn more

    Already have an account?